US FDA accepts GSK’s submission for the use of Nucala to treat patients with chronic obstructive pulmonary disease: London, UK Wednesday, December 11, 2024, 10:00 Hrs [IST] GSK ...

More than 11 million people in the United States are living with chronic obstructive pulmonary disease (COPD), including more than 3 million people with emphysema, a type of COPD. This chronic lung ...

Residents of Timișoara, in western Romania, can undergo free spirometry tests in a special tram as part of the ...

Patients with COPD diagnosed in-hospital vs in a primary care setting tended to be older, men, and had a greater number of comorbidities.

Sunway Medical Centre, Sunway City consultant physician, respiratory medicine and interventional pulmonologist Dr Syed Ajmal Syed Ali said that low awareness is one of Malaysia's biggest challenges in ...

For patients with severely compromised lung function, an important treatment is supplemental oxygen. Flawed Medicare payment ...

人活一口气 ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...

The FDA has accepted for review the BLA for mepolizumab as an add-on maintenance treatment for eosinophilic COPD.

London: GSK plc has announced the US Food and Drug Administration (FDA) has accepted for review, data from the MATINEE study ...

Obesity has this year overtaken smoking as Australia's leading risk factor contributing to disease, according to a national ...

Asthma, pneumonia and over 20 other conditions affecting the lungs and respiratory system are supported by PIP and ADP.